Senores Pharmaceuticals to acquire 3.73% paid up share capital of Havix

12 Mar 2025 Evaluate

Senores Pharmaceuticals has entered into the Share Purchase agreement (SPA) with certain shareholders (Public Category) of Havix Group Inc. D/B/A Aavis Pharmaceuticals (Havix) for acquisition of 8454 equity shares of Havix aggregating to 3.73% of the total paid up share capital of Havix and subject to the terms and conditions as mentioned in the SPA.

Further, post the aforesaid acquisition, the shareholding of the Company in Havix will increase from 51.23% to 54.96%. The said acquisition will be completed within the period of 10 days from the date of execution of SPA.

Senores Pharmaceuticals is global research driven pharmaceutical company engaged in developing and manufacturing a wide range of generic pharmaceutical products in the B2B segment predominantly for the Regulated Markets across various therapeutic areas and dosage forms.

Senores Pharmaceutic Share Price

516.00 -17.20 (-3.23%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...